Table 2a.
Interventional characteristics of TAVI for BAV patients
| Liu | Bauer | Kochman | Costopoulos | Hayashida | Kosek | Himbert | Wijesinghe | |
|---|---|---|---|---|---|---|---|---|
| Number of patients | 15 | 38 | 28 | 21 | 21 | 7 | 15 | 11 |
| Type of valve | ||||||||
| Edwards, n (%) | 10 (66.7) | 12 (31.6) | 5 (17.9) | 8 (38.1) | 11 (52.4) | 2 (28.6) | 0 | 11 (100) |
| Corevalve, n (%) | 5 (33.3) | 26 (68.4) | 23 (82.1) | 13 (61.9) | 10 (47.6) | 5 (71.4) | 15 (100) | 0 |
| Acess route | ||||||||
| Transfemoral, n (%) | 13 (86.7) | 31 (81.6) | 22 (78.6) | 15 (71.4) | 13 (61.9) | 5 (71.4) | 14 (93.3) | 7 (63.6) |
| Transapical, n (%) | 0 | 6 (15.8) | 3 (10.7) | 1 (4.8) | 3 (14.3) | 1 (14.3) | 0 | 4 (36.4) |
| Others, n (%) | 2 (13.3) | 1 (2.6) | 3 (10.7) | 5 (23.8) | 5 (23.8) | 1 (14.3) | 1 (6.7) | 0 |
| Valve size | ||||||||
| Edwards | ||||||||
| 23 mm, n (%) | 0 | NR | 3 (10.7) | 2 (9.5) | 5 (23.8) | 2 (28.6) | 0 | 1 (9.1) |
| 26 mm, n (%) | 1 (6.7) | NR | 1 (3.6) | 5 (23.8) | 2 (9.6) | 0 | 0 | 10 (90.1) |
| 29 mm, n (%) | 9 (60.0) | NR | 1 (3.6) | 1 (4.8) | 4 (19.0) | 0 | 0 | 0 |
| Corevalve | ||||||||
| 26 mm, n (%) | 0 | NR | 2 (7.1) | 2 (9.5) | 0 | 2 (28.6) | 2 (13.3) | 0 |
| 29 mm, n (%) | 2 (13.3) | NR | 18 (64.3) | 10 (47.6) | 5 (23.8) | 3 (42.8) | 13 (86.7) | 0 |
| 31 mm, n (%) | 3 (20.0) | NR | 3 (10.7) | 1 (4.8) | 5 (23.8) | 0 | 0 | 0 |
TAVI: transcatheter aortic valve implantation; BAV: bicuspid aortic valve; NR: not reported